JP2024099590A5 - - Google Patents

Download PDF

Info

Publication number
JP2024099590A5
JP2024099590A5 JP2024063716A JP2024063716A JP2024099590A5 JP 2024099590 A5 JP2024099590 A5 JP 2024099590A5 JP 2024063716 A JP2024063716 A JP 2024063716A JP 2024063716 A JP2024063716 A JP 2024063716A JP 2024099590 A5 JP2024099590 A5 JP 2024099590A5
Authority
JP
Japan
Prior art keywords
composition
component
bilberry
dosage form
oral dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024063716A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024099590A (ja
Filing date
Publication date
Priority claimed from PCT/US2016/059226 external-priority patent/WO2018080510A1/en
Application filed filed Critical
Priority to JP2024063716A priority Critical patent/JP2024099590A/ja
Publication of JP2024099590A publication Critical patent/JP2024099590A/ja
Publication of JP2024099590A5 publication Critical patent/JP2024099590A5/ja
Pending legal-status Critical Current

Links

JP2024063716A 2016-10-27 2024-04-11 腸の健康を促す組成物 Pending JP2024099590A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024063716A JP2024099590A (ja) 2016-10-27 2024-04-11 腸の健康を促す組成物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US2016/059226 WO2018080510A1 (en) 2016-10-27 2016-10-27 Intestinal health promoting compositions
JP2019545873A JP7011885B2 (ja) 2016-10-27 2016-10-27 腸の健康を促す組成物
JP2021189726A JP7473516B2 (ja) 2016-10-27 2021-11-22 腸の健康を促す組成物
JP2024063716A JP2024099590A (ja) 2016-10-27 2024-04-11 腸の健康を促す組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021189726A Division JP7473516B2 (ja) 2016-10-27 2021-11-22 腸の健康を促す組成物

Publications (2)

Publication Number Publication Date
JP2024099590A JP2024099590A (ja) 2024-07-25
JP2024099590A5 true JP2024099590A5 (https=) 2024-11-08

Family

ID=62023893

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019545873A Active JP7011885B2 (ja) 2016-10-27 2016-10-27 腸の健康を促す組成物
JP2021189726A Active JP7473516B2 (ja) 2016-10-27 2021-11-22 腸の健康を促す組成物
JP2024063716A Pending JP2024099590A (ja) 2016-10-27 2024-04-11 腸の健康を促す組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2019545873A Active JP7011885B2 (ja) 2016-10-27 2016-10-27 腸の健康を促す組成物
JP2021189726A Active JP7473516B2 (ja) 2016-10-27 2021-11-22 腸の健康を促す組成物

Country Status (5)

Country Link
US (2) US20190255134A1 (https=)
JP (3) JP7011885B2 (https=)
KR (1) KR20190079641A (https=)
CN (1) CN110636760B (https=)
WO (1) WO2018080510A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190255134A1 (en) * 2016-10-27 2019-08-22 Nse Products, Inc. Intestinal health promoting compositions
KR102178556B1 (ko) * 2019-03-21 2020-11-13 강원대학교산학협력단 마늘껍질 추출물을 포함하는 장내균총 개선용 프리바이오틱스 조성물 및 이를 포함하는 기능성 식품
FR3097122B1 (fr) * 2019-06-11 2021-06-18 Valbiotis Melange d’extraits de plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l’intestin
CN110283754B (zh) * 2019-07-11 2021-02-02 中国科学院北京基因组研究所 用于类风湿关节炎炎症状态评估及预后评价的肠道微生物菌群
IT201900019325A1 (it) * 2019-10-18 2021-04-18 Ghs Gemelli Health System S R L Miscela comprendente estratti di frutti, e polifenoli estratti da foglie o frutti di Olea Europaea L. e inulina e uso di tale composizione nel trattamento di malattie infiammatorie acute e croniche, localizzate o sistemiche, o conseguenti ad un’ischemia o a un’alterazione della funzionalità dell’endotelio vasale
WO2021193703A1 (ja) * 2020-03-24 2021-09-30 学校法人 芝浦工業大学 中枢神経賦活組成物
KR20210156445A (ko) 2020-06-18 2021-12-27 종근당건강 주식회사 들쭉나무 열매 분말 또는 추출물을 함유하는 장내 환경 개선용 조성물
CN115988969A (zh) * 2020-08-25 2023-04-18 国立大学法人熊本大学 用于改善伴随月经产生的不适状态的组合物
JP2023124967A (ja) * 2022-02-28 2023-09-07 アスパック企業株式会社 腸内環境改善剤
CN115645429B (zh) * 2022-12-12 2023-05-16 汤臣倍健股份有限公司 一种花色苷组合物及其应用
JP2026503891A (ja) * 2023-01-04 2026-02-02 エヌエスイー プロダクツ、インク. 代謝健康促進組成物
CN116790402B (zh) * 2023-01-14 2024-05-14 西北农林科技大学 一株具有抗炎特性的单形拟杆菌菌株、培养方法及应用
CN117085117B (zh) * 2023-09-14 2024-03-12 浙江花开星辰生物科技有限公司 一种洋甘菊提取物的抗幽门螺旋杆菌组合物及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6801200A (en) * 1999-08-27 2001-03-26 Amway Corporation Dietary food supplement containing natural cyclooxygenase inhibitors
US8337914B2 (en) * 2002-02-27 2012-12-25 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
JP2004099578A (ja) 2002-09-04 2004-04-02 Oriza Yuka Kk 美肌用組成物
US20070243268A1 (en) * 2005-11-07 2007-10-18 Jaffe Russell M Compositions for regulating intestinal disorders and methods of use thereof
EP1882473A1 (en) * 2006-07-28 2008-01-30 Indena S.P.A. Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs
JP2008271878A (ja) * 2007-04-27 2008-11-13 Wakasa Seikatsu:Kk 新規飲食品
JP5877902B2 (ja) 2011-08-17 2016-03-08 マイクロバイオーム セラピューティクス,エルエルシー バクテロイデス門の胃腸管微生物相対フィルミクテス門の微生物相の比を上昇させるための組成物および製剤の使用
EP2682005A1 (en) * 2012-07-05 2014-01-08 Symrise AG A dietary supplement composition
EP2710901A1 (en) * 2012-09-20 2014-03-26 Symrise AG Dietary supplement compositions
US20140128333A1 (en) * 2012-11-02 2014-05-08 Maqui New Life S.A. Compounds, Compositions, and Methods for Decreasing Intestinal Glucose Uptake and Inducing Incretin Release
AU2014236655B2 (en) * 2013-03-15 2017-06-29 Mars, Incorporated Edible pet chew and method of making the same
US20190255134A1 (en) * 2016-10-27 2019-08-22 Nse Products, Inc. Intestinal health promoting compositions

Similar Documents

Publication Publication Date Title
JP2024099590A5 (https=)
RU2536939C2 (ru) Композиции, содержащие пробиотические и пребиотические компоненты и неорганические соли с лактоферрином
Navaneethan et al. Mechanisms of infectious diarrhea
JP2015531770A5 (https=)
JP2022036990A5 (https=)
US11998558B2 (en) Synthetic composition for treating antibiotic associated complications
Gassull The role of nutrition in the treatment of inflammatory bowel disease
Sun et al. Metabolic regulation mechanism of fucoidan via intestinal microecology in diseases
EP3131568B1 (en) Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
Ma et al. The role of intestinal microbiota and metabolites in intestinal inflammation
WO2009020595A2 (en) Nutritional supplement system
Peng et al. Bioorthogonal conjugation and responsive nanocoating of probiotics for inflammatory bowel disease
JP2020513014A5 (https=)
JP2019534331A5 (https=)
JPWO2020166527A5 (https=)
CA3116039A1 (en) Human dietary supplement and method for treating digestive system and immune-related disorders
Zhang et al. Dietary fibers: structural aspects and nutritional implications
Kelly Infectious diarrhoea
JP2009519897A5 (https=)
ITMI20130960A1 (it) Composizioni a base di xiloglucano per il trattamento di disturbi gastrointestinali
Abdolghaffari et al. Dietary fiber and aging
JP2020092719A5 (https=)
Rozemeijer et al. Vibrio cholerae non-O1 non-O139 infection in an immunocompromised patient returning from Spain, July 2009
JPWO2023187097A5 (https=)
Chakrabarty et al. Dietary Fibers